This is a Validated Antibody Database (VAD) review about dog LOC610636, based on 5 published articles (read how Labome selects the articles), using LOC610636 antibody in all methods. It is aimed to help Labome visitors find the most suited LOC610636 antibody. Please note the number of articles fluctuates since newly identified citations are added and citations for discontinued catalog numbers are removed regularly.
LOC610636 synonym: TUBA3C; TUBA3D; tubulin alpha-1D chain; tubulin alpha-1B chain; tubulin alpha-8 chain; tubulin, alpha 3c; tubulin, alpha 3d
others
| |
| LOC610636 antibody (Proteintech, 1E4C11) was used in western blot on human samples at 1:10,000 (fig 3e). Nature (2018) ncbi |
Proteintech Group
| mouse monoclonal (1E4C11) |
| Proteintech Group LOC610636 antibody (Proteintech, 1E4C11) was used in western blot on human samples at 1:10,000 (fig 3e). Nature (2018) ncbi |
| mouse monoclonal (1E4C11) |
| Proteintech Group LOC610636 antibody (Proteintech, 66031-1-Ig) was used in western blot on human samples at 1:5000 (fig 2). PLoS Pathog (2016) ncbi |
| mouse monoclonal (1E4C11) |
| Proteintech Group LOC610636 antibody (Protein Tech Group, 66031-1-Ig) was used in western blot on human samples at 1:1000 (fig 1). Nucleic Acids Res (2015) ncbi |
| mouse monoclonal (1E4C11) |
| Proteintech Group LOC610636 antibody (Proteintech, 66031-1-Ig) was used in western blot on rat samples at 1:5000. Biomed Rep (2015) ncbi |
| mouse monoclonal (1E4C11) |
| Proteintech Group LOC610636 antibody (Proteintechnology, 66031-1-1g) was used in western blot on human samples (fig 1). Oncotarget (2015) ncbi |
Articles Reviewed
- Zhang L, Feng D, Tao H, DE X, Chang Q, Hu Q. Increased stathmin expression strengthens fear conditioning in epileptic rats. Biomed Rep. 2015;3:28-32 pubmed
- Xu M, Zhu C, Zhao X, Chen C, Zhang H, Yuan H, et al. Atypical ubiquitin E3 ligase complex Skp1-Pam-Fbxo45 controls the core epithelial-to-mesenchymal transition-inducing transcription factors. Oncotarget. 2015;6:979-94 pubmed
contribute
- If you are aware of any publication with knockout studies validating a monoclonal or recombinant antibody, either purchased from a supplier or developed by the author(s), please notify us through feedback.
questions and comments
